Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 127, Issue 18
May 5 2016
Issue Cover

Table of Contents

ANNIVERSARY EDITORIAL

Blood’s 70th anniversary: the elusive von Willebrand factor–cleaving protease
Kenneth Kaushansky
View Articletitled, <em>Blood</em>’s 70th anniversary: the elusive von Willebrand factor–cleaving protease

BLOOD FLASHBACK

Heyssel R, Brill AB, Woodbury LA, et al. Leukemia in Hiroshima atomic bomb survivors. Blood. 1960;15(3):313-331.
View Articletitled, Heyssel R, Brill AB, Woodbury LA, et al. Leukemia in Hiroshima atomic bomb survivors. <em>Blood</em>. 1960;15(3):<span class="related-article">313-331</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Bleomycin for older patients: less is more
Clinical Trials & Observations
Alison J. Moskowitz
View Articletitled, Bleomycin for older patients: less is more
INSIDE BLOOD COMMENTARY
NEDD8 and HDACs: promising cotargets in AML
Kapil N. Bhalla,Warren Fiskus
View Articletitled, NEDD8 and HDACs: promising cotargets in AML
INSIDE BLOOD COMMENTARY
Antibodies are back for thymic attack in cGVHD
Stefanie Sarantopoulos
View Articletitled, Antibodies are back for thymic attack in cGVHD

REVIEW ARTICLE

Neutrophil heterogeneity: implications for homeostasis and pathogenesis
Carlos Silvestre-Roig,Andres Hidalgo,Oliver Soehnlein
View Articletitled, Neutrophil heterogeneity: implications for homeostasis and pathogenesis
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Clinical Trials & Observations
Kerry J. Savage,Graham W. Slack,Anja Mottok,Laurie H. Sehn,Diego Villa,Roopesh Kansara,Robert Kridel,Christian Steidl,Daisuke Ennishi,King L. Tan,Susana Ben-Neriah,Nathalie A. Johnson,Joseph M. Connors,Pedro Farinha,David W. Scott,Randy D. Gascoyne
View Articletitled, Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Supplemental data
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
Clinical Trials & Observations Brief Report
Boris Böll,Helen Goergen,Karolin Behringer,Paul J. Bröckelmann,Felicitas Hitz,Andrea Kerkhoff,Richard Greil,Bastian von Tresckow,Dennis A. Eichenauer,Carolin Bürkle,Sven Borchmann,Michael Fuchs,Volker Diehl,Andreas Engert,Peter Borchmann
View Articletitled, Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials

IMMUNOBIOLOGY

Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome
Ales Janda,Klaus Schwarz,Mirjam van der Burg,Werner Vach,Hanna Ijspeert,Myriam Ricarda Lorenz,Magdeldin Elgizouli,Kathrin Pieper,Paul Fisch,Joachim Hagel,Raquel Lorenzetti,Maximilian Seidl,Joachim Roesler,Fabian Hauck,Elisabetta Traggiai,Carsten Speckmann,Anne Rensing-Ehl,Stephan Ehl,Hermann Eibel,Marta Rizzi
View Articletitled, Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome
Supplemental data

LYMPHOID NEOPLASIA

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Bjoern Chapuy,Hongwei Cheng,Akira Watahiki,Matthew D. Ducar,Yuxiang Tan,Linfeng Chen,Margaretha G. M. Roemer,Jing Ouyang,Amanda L. Christie,Liye Zhang,Daniel Gusenleitner,Ryan P. Abo,Pedro Farinha,Frederike von Bonin,Aaron R. Thorner,Heather H. Sun,Randy D. Gascoyne,Geraldine S. Pinkus,Paul van Hummelen,Gerald G. Wulf,Jon C. Aster,David M. Weinstock,Stefano Monti,Scott J. Rodig,Yuzhuo Wang,Margaret A. Shipp
View Articletitled, Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Supplemental data
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications
Brief Report
Claire Schwab,Sarra L. Ryan,Lucy Chilton,Alannah Elliott,James Murray,Stacey Richardson,Christopher Wragg,John Moppett,Michelle Cummins,Oliver Tunstall,Catriona A. Parker,Vaskar Saha,Nicholas Goulden,Ajay Vora,Anthony V. Moorman,Christine J. Harrison
View Articletitled, <em>EBF1-PDGFRB</em> fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications
Supplemental data

MYELOID NEOPLASIA

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR
Liang Zhou,Shuang Chen,Yu Zhang,Maciej Kmieciak,Yun Leng,Lihong Li,Hui Lin,Kathryn A. Rizzo,Catherine I. Dumur,Andrea Ferreira-Gonzalez,Mohamed Rahmani,Lawrence Povirk,Sri Chalasani,Allison J. Berger,Yun Dai,Steven Grant
View Articletitled, The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR
Supplemental data

PLATELETS AND THROMBOPOIESIS

Aryl hydrocarbon receptor–dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets
Catherine Strassel,Nathalie Brouard,Lea Mallo,Nicolas Receveur,Pierre Mangin,Anita Eckly,Ivan Bieche,Karin Tarte,Christian Gachet,François Lanza
View Articletitled, Aryl hydrocarbon receptor–dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets
Supplemental data

THROMBOSIS AND HEMOSTASIS

Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII
Kelly Njine Mouapi,Jacob D. Bell,Kerrie A. Smith,Robert A. S. Ariëns,Helen Philippou,Muriel C. Maurer
View Articletitled, Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII
Supplemental data

TRANSPLANTATION

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice
Hua Jin,Xiong Ni,Ruishu Deng,Qingxiao Song,James Young,Kaniel Cassady,Mingfeng Zhang,Stephen Forman,Paul J. Martin,Qifa Liu,Defu Zeng
View Articletitled, Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice
Supplemental data

LETTERS TO BLOOD

Elevated D-dimer levels in African Americans with sickle cell trait
Clinical Trials & Observations
Rakhi P. Naik,James G. Wilson,Lynette Ekunwe,Stanford Mwasongwe,Qing Duan,Yun Li,Adolfo Correa,Alexander P. Reiner
View Articletitled, Elevated D-dimer levels in African Americans with sickle cell trait

BLOOD WORK

Unexpected cause of high fever in the blood film
Clinical Trials & Observations
Rudolf Benz,Sabine Majer
View Articletitled, Unexpected cause of high fever in the blood film
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals